{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:04:37Z","timestamp":1790701477404,"version":"4.1.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00277800"],"award-info":[{"award-number":["RS-2023-00277800"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00398030"],"award-info":[{"award-number":["RS-2024-00398030"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biotechadv.2026.109022","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:37:00Z","timestamp":1787614620000},"page":"109022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ex vivo live macrophage engineering strategies in immunotherapy"],"prefix":"10.1016","volume":"93","author":[{"given":"Eunha","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyobum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2026.109022_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1512494","article-title":"Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products","volume":"16","author":"Alfar","year":"2025","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.biotechadv.2026.109022_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115693","article-title":"Review of eukaryote cellular membrane lipid composition, with special attention to the fatty acids","volume":"24","author":"Ali","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"34","key":"10.1016\/j.biotechadv.2026.109022_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304040","article-title":"Cell surface engineering tools for programming living assemblies","volume":"10","author":"Almeida-Pinto","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41698-025-01170-7","article-title":"CAR-macrophages in solid tumors: promise, progress, and prospects","volume":"9","author":"Alrehaili","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0025","doi-asserted-by":"crossref","first-page":"0023","DOI":"10.34133\/cancomm.0023","article-title":"Harnessing the power of CAR-NK cells for solid tumors: challenges, innovations, and future frontiers in immunotherapy","volume":"46","author":"An","year":"2026","journal-title":"Cancer Commun."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0030","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3389\/fimmu.2018.02629","article-title":"Targeting macrophage-recruiting chemokines as a novel therapeutic strategy to prevent the progression of solid tumors","volume":"9","author":"Argyle","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cell.2018.05.059","article-title":"Size-dependent segregation controls macrophage phagocytosis of antibody-opsonized targets","volume":"174","author":"Bakalar","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/imm.13300","article-title":"Macrophage reprogramming for therapy","volume":"163","author":"Bart","year":"2021","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.immuni.2020.06.014","article-title":"Immune sensing mechanisms that discriminate self from altered self and foreign nucleic acids","volume":"53","author":"Bartok","year":"2020","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0055","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"6657","key":"10.1016\/j.biotechadv.2026.109022_bb0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0065","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1021\/acs.bioconjchem.1c00461","article-title":"Bioorthogonal chemistry and its applications","volume":"32","author":"Bird","year":"2021","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s44385-026-00072-y","article-title":"Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential","volume":"3","author":"Block","year":"2026","journal-title":"NPJ Biomed. Innov."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0075","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41551-025-01387-8","article-title":"Targeting inflammation with chimeric antigen receptor macrophages using a signal switch","volume":"9","author":"Cao","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0080","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7555\/JBR.38.20240009","article-title":"Systemic lupus erythematosus therapeutic strategy: from immunotherapy to gut microbiota modulation","volume":"38","author":"Chasov","year":"2024","journal-title":"J. Biomed. Res."},{"issue":"41","key":"10.1016\/j.biotechadv.2026.109022_bb0090","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1039\/D1SC03997K","article-title":"Polyvalent spherical aptamer engineered macrophages: X-ray-actuated phenotypic transformation for tumor immunotherapy","volume":"12","author":"Chen","year":"2021","journal-title":"Chem. Sci."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0095","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.32604\/or.2023.042383","article-title":"Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy","volume":"32","author":"Chen","year":"2023","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12967-023-04479-8","article-title":"The application of HER2 and CD47 CAR-macrophage in ovarian cancer","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0115","article-title":"Dendritic cell subsets and implications for cancer immunotherapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0120","article-title":"Specific macrophage RhoA targeting CRISPR-Cas9 for mitigating osteoclastogenesis-induced joint damage in inflammatory arthritis","volume":"6","author":"Chen","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0125","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1038\/s41467-025-59326-9","article-title":"CAR macrophages with built-in CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jare.2025.01.004","article-title":"Exploring CAR-macrophages in non-tumor diseases: therapeutic potential beyond cancer","volume":"77","author":"Chen","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-026-01792-9","article-title":"Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies","volume":"19","author":"Chen","year":"2026","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00262-024-03759-6","article-title":"Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers","volume":"73","author":"Chupradit","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0145","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/annonc\/mdz285","article-title":"Development of adaptive immune effector therapies in solid tumors","volume":"30","author":"Comoli","year":"2019","journal-title":"Ann. Oncol."},{"issue":"34","key":"10.1016\/j.biotechadv.2026.109022_bb0150","doi-asserted-by":"crossref","first-page":"54392","DOI":"10.18632\/oncotarget.11106","article-title":"Myeloid cell expressed proprotein convertase FURIN attenuates inflammation","volume":"7","author":"Cordova","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0155","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1021\/acsabm.3c00720","article-title":"Magnetic cellular backpacks for spatial targeting, imaging, and immunotherapy","volume":"7","author":"Day","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"38","key":"10.1016\/j.biotechadv.2026.109022_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq5226","article-title":"NF-kappaB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment","volume":"10","author":"de la Calle-Fabregat","year":"2024","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/open.201900290","article-title":"Surface modification with control over ligand density for the study of multivalent biological systems","volume":"9","author":"Di Iorio","year":"2020","journal-title":"ChemistryOpen"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0175","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymthe.2017.01.011","article-title":"Inducible Caspase-9 selectively modulates the toxicities of CD19-specific chimeric antigen receptor-modified T cells","volume":"25","author":"Diaconu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1640935","article-title":"Comprehensive review of macrophage models: primary cells and immortalized lines across species","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"issue":"29","key":"10.1016\/j.biotechadv.2026.109022_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202309038","article-title":"ZIF-8-encapsulated Pexidartinib delivery via targeted peptide-modified M1 macrophages attenuates MDSC-mediated immunosuppression in osteosarcoma","volume":"20","author":"Dong","year":"2024","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0190","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/JLB.1MR0520-746R","article-title":"Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors","volume":"108","author":"Donnadieu","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0195","doi-asserted-by":"crossref","first-page":"H105","DOI":"10.1002\/adma.201004074","article-title":"Cell-based drug delivery devices using phagocytosis-resistant backpacks","volume":"23","author":"Doshi","year":"2011","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.18","article-title":"Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells","volume":"6","author":"Dransfield","year":"2015","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0205","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.1601520","article-title":"Efferocytosis signaling in the regulation of macrophage inflammatory responses","volume":"198","author":"Elliott","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662063","article-title":"Microbial phagocytic receptors and their potential involvement in cytokine induction in macrophages","volume":"12","author":"Fu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202270081","article-title":"Surface modification of erythrocytes with lipid anchors: structure-activity relationship for optimal membrane incorporation, in vivo retention, and immunocompatibility","volume":"2","author":"Gaikwad","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109022_bb0225","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1021\/nn502325j","article-title":"Plasmon-mediated generation of reactive oxygen species from near-infrared light excited gold nanocages for photodynamic therapy in vitro","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0230","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"43","key":"10.1016\/j.biotechadv.2026.109022_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202417677","article-title":"Lifespan-regulated CAR-macrophages from myeloid progenitors for enhanced colorectal cancer therapy","volume":"12","author":"Gao","year":"2025","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0240","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0245","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0250","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.biotechadv.2026.109022_bb0255","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41388-025-03332-0","article-title":"Human CSPG4-targeting CAR-macrophages inhibit melanoma growth","volume":"44","author":"Greiner","year":"2025","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109022_bb0260","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/cm2032459","article-title":"Polyelectrolyte multilayer assemblies on materials surfaces: from cell adhesion to tissue engineering","volume":"24","author":"Gribova","year":"2012","journal-title":"Chem. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0265","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-025-67674-9","article-title":"Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy","volume":"17","author":"Gu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0270","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0275","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.32604\/or.2025.071708","article-title":"CD47-targeted therapy in cancer immunotherapy: at a crossroads of promise and challenge","volume":"33","author":"Guo","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0280","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251316604","article-title":"Macrophage polarisation in the tumour microenvironment: recent research advances and therapeutic potential of different macrophage reprogramming","volume":"32","author":"Guo","year":"2025","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40364-023-00537-x","article-title":"The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors","volume":"11","author":"Hadiloo","year":"2023","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0290","article-title":"Safety and optimization of metabolic labeling of endothelial progenitor cells for tracking","volume":"8","author":"Han","year":"2018","journal-title":"Sci. Rep."},{"issue":"39","key":"10.1016\/j.biotechadv.2026.109022_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1252","article-title":"Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset","volume":"10","author":"Hanlon","year":"2024","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0300","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41573-020-0074-8","article-title":"Antitumour dendritic cell vaccination in a priming and boosting approach","volume":"19","author":"Harari","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109022_bb0305","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1039\/D5CB00168D","article-title":"Achieving cell-type selectivity in metabolic oligosaccharide engineering","volume":"6","author":"Helmeke","year":"2025","journal-title":"RSC Chem. Biol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279037","article-title":"Expanded characterization of in vitro polarized M0, M1, and M2 human monocyte-derived macrophages: bioenergetic and secreted mediator profiles","volume":"18","author":"Hickman","year":"2023","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0315","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s44222-024-00219-9","article-title":"Genetically engineered hypoimmunogenic cell therapy","volume":"2","author":"Hotta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1464218","article-title":"CAR-macrophage: breaking new ground in cellular immunotherapy","volume":"12","author":"Huang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0325","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-med.2024.100050","article-title":"CRISPRa engineered elite macrophages enable adoptive cell therapy for rheumatoid arthritis","volume":"2","author":"Huang","year":"2024","journal-title":"Innovation Med."},{"issue":"SI","key":"10.1016\/j.biotechadv.2026.109022_bb0330","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlaf089","article-title":"Macrophages in human atherosclerotic plaques in the era of single-cell and spatial transcriptomics","volume":"10","author":"Ijaz","year":"2026","journal-title":"Immunohorizons"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0335","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nri1375","article-title":"Adhesion mechanisms regulating the migration of monocytes","volume":"4","author":"Imhof","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"41","key":"10.1016\/j.biotechadv.2026.109022_bb0340","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1021\/ja507832e","article-title":"Lipid organization of the plasma membrane","volume":"136","author":"Ing\u00f3lfsson","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0345","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri.2017.28","article-title":"Monocyte differentiation and antigen-presenting functions","volume":"17","author":"Jakubzick","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0350","doi-asserted-by":"crossref","first-page":"61","DOI":"10.46989\/001c.121404","article-title":"Allogeneic and other innovative chimeric antigen receptor platforms","volume":"6","author":"Jallouk","year":"2024","journal-title":"Clin. Hematol. Int."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0355","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/2326-6066.CIR-24-0797","article-title":"Sustained macrophage reprogramming is required for CD8+ T cell-dependent Long-term tumor eradication","volume":"13","author":"Jardim","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0360","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2021.10.015","article-title":"CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109022_bb0365","first-page":"838","article-title":"An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma","volume":"6","author":"Jing","year":"2025","journal-title":"Nat. Can."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0370","article-title":"Association between CCR2 and CCL2 expression and NET stimulation in adult-onset still\u2019s disease","volume":"13","author":"Jung","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad434","article-title":"Backpack-mediated anti-inflammatory macrophage cell therapy for the treatment of traumatic brain injury","volume":"3","author":"Kapate","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213059","article-title":"Lipid-mediated ex vivo cell surface engineering for augmented cellular functionalities","volume":"140","author":"Kim","year":"2022","journal-title":"Biomater. Adv."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0385","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s13233-025-00442-2","article-title":"Optimization of lipid variants in lipid-PEG conjugates for triple-negative breast cancer cell surface modification","volume":"33","author":"Kim","year":"2025","journal-title":"Macromol. Res."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0390","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0395","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.06.017","article-title":"Macrophages with cellular backpacks for targeted drug delivery to the brain","volume":"140","author":"Klyachko","year":"2017","journal-title":"Biomaterials"},{"issue":"7536","key":"10.1016\/j.biotechadv.2026.109022_bb0400","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0405","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/ar500260t","article-title":"The structural role of cholesterol in cell membranes: from condensed bilayers to lipid rafts","volume":"47","author":"Krause","year":"2014","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0410","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1039\/D2CS00764A","article-title":"Metabolic glycoengineering\u2013exploring glycosylation with bioorthogonal chemistry","volume":"52","author":"Kufleitner","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0415","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jconrel.2024.12.018","article-title":"Metabolic glycan labelling with bio-orthogonal targeting and its potential in drug delivery","volume":"378","author":"Lam","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-065X.2002.18604.x","article-title":"Rapid leukocyte integrin activation by chemokines","volume":"186","author":"Laudanna","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0425","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2016.07.018","article-title":"Macrophage-based cell therapies: the long and winding road","volume":"240","author":"Lee","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0430","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/mt.2014.47","article-title":"Reversal of tumor immune inhibition using a chimeric cytokine receptor","volume":"22","author":"Leen","year":"2014","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.biotechadv.2026.109022_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201807211","article-title":"Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation","volume":"31","author":"Li","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0445","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40164-024-00549-9","article-title":"The next frontier in immunotherapy: potential and challenges of CAR-macrophages","volume":"13","author":"Li","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0450","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-024-01635-5","article-title":"A clinical study of autologous chimeric antigen receptor macrophage targeting mesothelin shows safety in ovarian cancer therapy","volume":"17","author":"Li","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1054938","article-title":"Engineered M2a macrophages for the treatment of osteoarthritis","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109022_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17101285","article-title":"Surface engineering of natural killer cells with lipid-based antibody capture platform for targeted chemoimmunotherapy","volume":"17","author":"Lim","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0465","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/hep.29033","article-title":"Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism","volume":"66","author":"Lin","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0470","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101089","article-title":"Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis","volume":"59","author":"Liner","year":"2025","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0480","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.1038\/s41598-023-33915-4","article-title":"CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0485","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1038\/s41467-024-52500-5","article-title":"Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0490","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40164-025-00683-y","article-title":"Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy","volume":"14","author":"Liu","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0495","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1021\/acssynbio.5c00395","article-title":"Thermally controlled state switches for engineered macrophages","volume":"14","author":"Liu","year":"2025","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0500","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0505","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40364-024-00637-2","article-title":"CAR macrophages: a promising novel immunotherapy for solid tumors and beyond","volume":"12","author":"Lu","year":"2024","journal-title":"Biomark. Res."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0510","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70374","article-title":"Chimeric antigen receptor-macrophage therapy enters the clinic: the first-in-human trial for HER2+ solid tumors","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm"},{"issue":"5315","key":"10.1016\/j.biotechadv.2026.109022_bb0515","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1126\/science.276.5315.1125","article-title":"Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis","volume":"276","author":"Mahal","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0520","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13036-026-00666-5","article-title":"Are we there yet? The road to faster and more efficient CAR T cell manufacturing","volume":"20","author":"Matos","year":"2026","journal-title":"J. Biol. Eng."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0530","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/cvr\/cvv154","article-title":"Selectins: initiators of leucocyte adhesion and signalling at the vascular wall","volume":"107","author":"McEver","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0535","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0540","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2020.07.008","article-title":"CD47 ligation repositions the inhibitory receptor SIRPA to suppress integrin activation and phagocytosis","volume":"53","author":"Morrissey","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0545","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-pathol-011110-130224","article-title":"Mechanisms of leukocyte transendothelial migration","volume":"6","author":"Muller","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0550","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0555","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/s12276-023-01068-z","article-title":"A new era of macrophage-based cell therapy","volume":"55","author":"Na","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0560","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2024.11.037","article-title":"Backpack-carrying macrophage immunotherapy for periodontitis","volume":"377","author":"Nakajima","year":"2025","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0565","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbalip.2016.09.002","article-title":"Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation","volume":"1861","author":"Namgaladze","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0570","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jconrel.2024.02.003","article-title":"Genetically engineered macrophages as living cell drug carriers for targeted cancer therapy","volume":"367","author":"Ning","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109022_bb0575","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.immuni.2014.10.008","article-title":"Leukocyte migration into inflamed tissues","volume":"41","author":"Nourshargh","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0580","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1871530315666150316120920","article-title":"CCL2-CCR2 signaling in disease pathogenesis","volume":"15","author":"O\u2019Connor","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0585","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41423-024-01145-x","article-title":"Development of NK cell-based cancer immunotherapies through receptor engineering","volume":"21","author":"Page","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0590","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0595","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-025-03209-0","article-title":"Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems","volume":"23","author":"Pan","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032971","article-title":"Insights of endocytosis signaling in health and disease","volume":"24","author":"Pathak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0605","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7150\/jca.126772","article-title":"Macrophages in colorectal cancer: from normal mucosa to distant metastasis: beyond the M1\/M2 paradigm","volume":"17","author":"Pavlov","year":"2026","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0610","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s12672-025-03258-9","article-title":"Advances in the regulation of macrophage polarization by the tumor microenvironment","volume":"16","author":"Peng","year":"2025","journal-title":"Discov. Oncol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0615","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20060925","article-title":"Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade","volume":"203","author":"Phillipson","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0620","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41467-024-55770-1","article-title":"Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","volume":"16","author":"Pierini","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0625","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0630","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.ymthe.2022.04.015","article-title":"Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy","volume":"30","author":"Qian","year":"2022","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109022_bb0635","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.trechm.2024.08.003","article-title":"Cholesterol-mediated functionalization of liposomes for artificial cell design","volume":"6","author":"Qiao","year":"2024","journal-title":"Trends Chem."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0640","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/0122115501294423240515110210","article-title":"Macrophages: balancing inflammation and homeostasis in health and disease","volume":"13","author":"Ramalingam","year":"2024","journal-title":"Curr. Biotechnol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0645","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"issue":"Pt 1","key":"10.1016\/j.biotechadv.2026.109022_bb0650","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0655","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642285","article-title":"Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes","volume":"12","author":"Ricketts","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0660","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.it.2023.10.004","article-title":"Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis","volume":"44","author":"Rodriguez-Morales","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1411393","article-title":"Engineering strategies to safely drive CAR T-cells into the future","volume":"15","author":"Rossi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1694892","article-title":"Macrophages: their role in immunity and their relationship with fatty acids in health and disease","volume":"16","author":"Rueda-Munguia","year":"2025","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.biotechadv.2026.109022_bb0675","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1021\/acs.chemmater.5c00658","article-title":"Membrane-inserting alpha-lipid polymers: understanding lipid membrane insertion and effect on membrane fluidity","volume":"37","author":"Schiazza","year":"2025","journal-title":"Chem. Mater."},{"issue":"24","key":"10.1016\/j.biotechadv.2026.109022_bb0680","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/adhm.201600797","article-title":"StarPEG-heparin hydrogels to protect and sustainably deliver IL-4","volume":"5","author":"Schirmer","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567661","article-title":"Perivascular RELMalpha-positive synovial macrophages recruit monocytes at the onset of inflammatory arthritis","volume":"16","author":"Schonfeldova","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0690","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.stem.2024.03.018","article-title":"Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer","volume":"31","author":"Shah","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295684","article-title":"Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs","volume":"14","author":"Shao","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0700","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0705","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-101320-031555","article-title":"Functional hallmarks of healthy macrophage responses: their regulatory basis and disease relevance","volume":"40","author":"Sheu","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0710","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.biotechadv.2026.109022_bb0715","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0720","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0725","article-title":"Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair","author":"Silver","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109022_bb0730","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/acsnano.4c08828","article-title":"Functional nanosheet immunoswitches reprogramming innate macrophages for immunotherapy of colorectal cancer and sepsis","volume":"19","author":"So","year":"2025","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0735","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/mnfr.201600014","article-title":"Enhanced M2 macrophage polarization in high n-3 polyunsaturated fatty acid transgenic mice fed a high-fat diet","volume":"60","author":"Song","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0740","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0745","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-025-01745-8","article-title":"Genome-edited allogeneic CAR-T cells: the next generation of cancer immunotherapies","volume":"18","author":"Su","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0750","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1021\/acs.bioconjchem.8b00793","article-title":"Surface modification of macrophages with nucleic acid aptamers for enhancing the immune response against tumor cells","volume":"29","author":"Sugimoto","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0755","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.4049\/jimmunol.1001638","article-title":"LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ","volume":"185","author":"Sumagin","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0760","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40364-022-00436-7","article-title":"Targeting toll-like receptor 7\/8 for immunotherapy: recent advances and prospectives","volume":"10","author":"Sun","year":"2022","journal-title":"Biomark. Res."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0765","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157011","article-title":"Through the layers: how macrophages drive atherosclerosis across the vessel wall","volume":"132","author":"Susser","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0770","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1021\/nl802404h","article-title":"Surface functionalization of living cells with multilayer patches","volume":"8","author":"Swiston","year":"2008","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24010172","article-title":"Click chemistry as a tool for cell engineering and drug delivery","volume":"24","author":"Takayama","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0780","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2795090","article-title":"The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"16","key":"10.1016\/j.biotechadv.2026.109022_bb0785","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303267","article-title":"Genetically engineered macrophages co-loaded with CD47 inhibitors synergistically reconstruct Efferocytosis and improve cardiac remodeling post myocardial ischemia reperfusion injury","volume":"13","author":"Tan","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0790","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3389\/fimmu.2020.02044","article-title":"Externally-controlled systems for immunotherapy: from bench to bedside","volume":"11","author":"Tristan-Manzano","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109022_bb0795","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.200708043","article-title":"Inhibition of \"self\" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells","volume":"180","author":"Tsai","year":"2008","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109022_bb0800","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites","volume":"117","author":"Tsou","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"29","key":"10.1016\/j.biotechadv.2026.109022_bb0805","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt1644","article-title":"Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing","volume":"11","author":"Valcarcel","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0810","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s41061-024-00467-8","article-title":"Mutually orthogonal bioorthogonal reactions: selective chemistries for labeling multiple biomolecules simultaneously","volume":"382","author":"Venrooij","year":"2024","journal-title":"Top. Curr. Chem."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0815","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2025.104982","article-title":"Revisiting TAM polarization: beyond M1- and M2-type TAM toward clinical precision in macrophage-targeted therapy","volume":"143","author":"Wang","year":"2025","journal-title":"Exp. Mol. Pathol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109022_bb0825","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1039\/C5TB02183A","article-title":"Enhanced cell membrane enrichment and subsequent cellular internalization of quantum dots via cell surface engineering: illuminating plasma membranes with quantum dots","volume":"4","author":"Wang","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107022","article-title":"Macrophage-related therapeutic strategies: regulation of phenotypic switching and construction of drug delivery systems","volume":"199","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0835","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40164-024-00558-8","article-title":"Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment","volume":"13","author":"Wang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0840","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/cac2.70053","article-title":"Harnessing chimeric antigen receptor macrophages against solid tumors","volume":"45","author":"Wang","year":"2025","journal-title":"Cancer Commun."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109022_bb0845","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jcyt.2025.04.062","article-title":"Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute\u2019s international cell therapy committee","volume":"27","author":"Watanabe","year":"2025","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0850","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","article-title":"Metabolism of tissue macrophages in homeostasis and pathology","volume":"19","author":"Wculek","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0855","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.suronc.2011.09.001","article-title":"The tumor microenvironment","volume":"21","author":"Weber","year":"2012","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0860","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.749210","article-title":"Characterizing intercellular communication of Pan-Cancer reveals SPP1+ tumor-associated macrophage expanded in hypoxia and promoting cancer malignancy through single-cell RNA-Seq data","volume":"9","author":"Wei","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0865","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.2147\/IJN.S421173","article-title":"Macrophages as promising carriers for nanoparticle delivery in anticancer therapy","volume":"18","author":"Wroblewska","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"7446","key":"10.1016\/j.biotechadv.2026.109022_bb0870","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.biotechadv.2026.109022_bb0875","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0880","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"17","key":"10.1016\/j.biotechadv.2026.109022_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37192","article-title":"Shaping the immune landscape: multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration","volume":"10","author":"Xue","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0890","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-024-46210-1","article-title":"Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0895","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14686996.2016.1240006","article-title":"Interaction of poly(ethylene glycol)-conjugated phospholipids with supported lipid membranes and their influence on protein adsorption","volume":"17","author":"Yamamoto","year":"2016","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0900","doi-asserted-by":"crossref","first-page":"e658","DOI":"10.1002\/mco2.658","article-title":"Macrophage plasticity: signaling pathways, tissue repair, and regeneration","volume":"5","author":"Yan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105576","article-title":"A sweet spot for macrophages: focusing on polarization","volume":"167","author":"Yang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117064","article-title":"Engineering M1 macrophages with targeting aptamers for enhanced adoptive immunotherapy by modifying the cell surface","volume":"177","author":"Yang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109022_bb0915","doi-asserted-by":"crossref","DOI":"10.3390\/membranes11080572","article-title":"Structure-dependent stability of lipid-based polymer amphiphiles inserted on erythrocytes","volume":"11","author":"Yu","year":"2021","journal-title":"Membranes"},{"key":"10.1016\/j.biotechadv.2026.109022_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0925","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.biotechadv.2026.109022_bb0930","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1021\/la400500t","article-title":"Photogeneration of reactive oxygen species on uncoated silver, gold, nickel, and silicon nanoparticles and their antibacterial effects","volume":"29","author":"Zhang","year":"2013","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0935","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0940","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.2147\/IJN.S436038","article-title":"A comprehensive review of small interfering RNAs (siRNAs): mechanism, therapeutic targets, and delivery strategies for cancer therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"23","key":"10.1016\/j.biotechadv.2026.109022_bb0945","doi-asserted-by":"crossref","first-page":"27457","DOI":"10.1021\/acsami.3c00489","article-title":"Heparin affinity-based IL-4 delivery to modulate macrophage phenotype and endothelial cell activity in vitro","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109022_bb0950","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41423-024-01220-3","article-title":"Silencing of SIRPalpha enhances the antitumor efficacy of CAR-M in solid tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109022_bb0955","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1021\/acs.molpharmaceut.4c01502","article-title":"Advances in T cell-based cancer immunotherapy: from fundamental mechanisms to clinical prospects","volume":"22","author":"Zhang","year":"2025","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0960","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41467-024-44941-9","article-title":"Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"issue":"29","key":"10.1016\/j.biotechadv.2026.109022_bb0965","doi-asserted-by":"crossref","first-page":"48436","DOI":"10.18632\/oncotarget.17061","article-title":"Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109022_bb0970","article-title":"Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy","volume":"2","author":"Zheng","year":"2022","journal-title":"Exploration"},{"issue":"32","key":"10.1016\/j.biotechadv.2026.109022_bb0975","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh2413","article-title":"Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy","volume":"9","author":"Zheng","year":"2023","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109022_bb0980","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ymthe.2024.12.014","article-title":"Potentiating CAR-T cell function in the immunosuppressive tumor microenvironment by inverting the TGF-beta signal","volume":"33","author":"Zheng","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biotechadv.2026.109022_bb0985","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.12659\/MSM.906626","article-title":"A Macaca Fascicularis knee osteoarthritis model developed by modified Hulth combined with joint scratches","volume":"24","author":"Zhou","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109022_bb0990","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5371","article-title":"The TLR7\/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer","volume":"61","author":"Zhou","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109022_bb0995","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41419-024-07267-4","article-title":"Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities","volume":"15","author":"Ziane-Chaouche","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:14Z","timestamp":1790698814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975026002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":199,"alternative-id":["S0734975026002284"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.109022","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo live macrophage engineering strategies in immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.109022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109022"}}